Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Astin Powers

Complete Pathological Response to Crizotinib in a Patient With ALK-rearranged Lung Adenocarcinoma

Clinical Lung Cancer

Cancer Research

Respiratory Medicine

English

Related publications

A Novel EML6-ALK FBXO11-ALK Double Fusion Variant in Lung Adenocarcinoma and Response to Crizotinib

Journal of Thoracic Oncology

Respiratory Medicine

English

Dramatic Response to Crizotinib in an ALK-Positive Adenocarcinoma Patient With Disseminated Intravascular Coagulation

Journal of Thoracic Oncology

Respiratory Medicine

English

A Case of ALK- Rearranged Adenocarcinoma With Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib

Journal of Thoracic Oncology

Respiratory Medicine

English

A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient With IHC-Positive and FISH-Negative ALK

Journal of Thoracic Oncology

Respiratory Medicine

English

P071 Variants Distribution and Heterogeneity of Outcomes to Crizotinib in ALK-Rearranged Chinese Non-Small Cell Lung Cancers

Journal of Thoracic Oncology

Respiratory Medicine

English

Miliary Brain Metastases in a Patient With ROS1-Rearranged Lung Adenocarcinoma: A Case Report

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-58 Variants Distribution and Heterogeneity of Outcomes to Crizotinib in ALK-Rearranged Chinese Non-Small Cell Lung Cancers

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-53 Local Treatment for Oligoprogression/Oligometastases After Failure to Crizotinib for ALK-Rearranged Stage IV Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P121 Clinical Value of Local Therapy in Advanced Crizotinib-Treated ALK-Rearranged Lung Cancer: Pattern of Failure Analyses

Journal of Thoracic Oncology

Respiratory Medicine

English